Irinotecan HCI Injection

Irinotecan HCI Injection

Product Details:

  • Drug Type Injection
  • Physical Form Liquid
  • Dosage 2 ml
  • Suitable For Aged Person, Adults, Women, Teenagers
  • Storage Instructions Store In a Cool Palace
  • Supply Ability : 100 Box Box Per Day
  • Click to view more
X

Price And Quantity

  • 1700 INR
  • 10 Box

Product Specifications

  • Store In a Cool Palace
  • 2 ml
  • Liquid
  • Aged Person, Adults, Women, Teenagers
  • Injection

Trade Information

  • Western Union, Telegraphic Transfer (T/T), Letter of Credit at Sight (Sight L/C), Cheque, Cash in Advance (CID), Cash Advance (CA)
  • 100 Box Box Per Day
  • 7 Days
  • Africa, Middle East, Western Europe, Eastern Europe, South America, North America, Central America, Australia, Asia
  • All India

Product Description

Irinotecan HCI Injection

Irinotecan HCI Injection is available as liquid to be given over 90 minutes intravenously (into a vein) usually not more often than once a week. Used alone or in combination with other medications, this is used in the treatment of cancer that begins in the large intestines.

Features

  • Irinotecan HCI Injection is used alone or in combination with other medications to treat colon or rectal cancer (cancer that begins in the large intestine)
  • Irinotecan is in a class of antineoplastic medications called topoisomerase inhibitors
  • It works by stopping the growth of cancer cells
  • Irinotecan comes as a liquid to be given over 90 minutes intravenously (into a vein) by a doctor or nurse
  • It is usually given not more often than once a week, according to a schedule that alternates one or more weeks when you receive irinotecan with one or more weeks when you do not receive the medication

3S CORPORATION

* Tips on getting accurate quotes. Please include product name, order quantity, usage, special requests if any in your inquiry.

Other Products in 'Life Saving Drugs' category



Back to top
3S CORPORATION All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Ltd.